Analysis by Clinical Mass Spectrometry of Bloodstains

CompletedOBSERVATIONAL

Enrollment

160

Participants

Timeline

Start Date

October 1, 2015

Primary Completion Date

March 1, 2017

Study Completion Date

September 1, 2018

Conditions

Patient Blood Biobank

Interventions

BIOLOGICAL

clinical biology analyzes spectrometry mass

Trial Locations (1)

LEHMANN, Montpellier

All Listed Sponsors

collaborator

SPOT-TO-LAB Montpellier

UNKNOWN

lead

University Hospital, Montpellier

OTHER

NCT02896634 - Analysis by Clinical Mass Spectrometry of Bloodstains | Biotech Hunter | Biotech Hunter